Literature DB >> 14119181

RATES OF GROWTH OF PULMONARY METASTASES AND HOST SURVIVAL.

J S SPRATT, T L SPRATT.   

Abstract

Keywords:  ADENOCARCINOMA; BONE NEOPLASMS; BREAST NEOPLASMS; CARCINOMA, EPIDERMOID; COLONIC NEOPLASMS; LIFE EXPECTANCY; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STATISTICS; RECTAL NEOPLASMS; TESTICULAR NEOPLASMS

Mesh：

Year:  1964        PMID： 14119181      PMCID： PMC1408505          DOI： 10.1097/00000658-196402000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  6 in total

1.  Effectiveness of radical mastectomy for mammary cancer: an analysis of mortalities by the method of probits.

Authors:  H R BUTCHER
Journal:  Ann Surg       Date:  1961-09       Impact factor: 12.969

2.  THE RATES AND PATTERNS OF GROWTH OF 375 TUMORS OF THE LARGE INTESTINE AND RECTUM OBSERVED SERIALLY BY DOUBLE CONTRAST ENEMA STUDY (MALMOE TECHNIQUE).

Authors:  S WELIN; J YOUKER; J S SPRATT
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1963-10

3.  The frequency distribution of the rates of growth and the estimated duration of primary pulmonary carcinomas.

Authors:  J S SPRATT; H J SPJUT; C L ROPER
Journal:  Cancer       Date:  1963-06       Impact factor: 6.860

4.  A biomathematical approach to clinical tumor growth.

Authors:  M SCHWARTZ
Journal:  Cancer       Date:  1961 Nov-Dec       Impact factor: 6.860

5.  The treatment of Wilms's tumor.

Authors:  V P COLLINS
Journal:  Cancer       Date:  1958 Jan-Feb       Impact factor: 6.860

6.  Differentiation of benign and malignant pulmonary nodules by growth rate.

Authors:  M H NATHAN; V P COLLINS; R A ADAMS
Journal:  Radiology       Date:  1962-08       Impact factor: 11.105
  6 in total
  32 in total

Review 1.  Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model.

Authors:  A Tejera-Vaquerizo; J Cañueto; A Toll; J Santos-Juanes; A Jaka; C Ferrandiz; O Sanmartín; S Ribero; D Moreno-Ramírez; F Almazán; M J Fuente; S Podlipnik; E Nagore
Journal:  Actas Dermosifiliogr       Date:  2020-09-20

2.  Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer.

Authors:  Hiroaki Miyake; Koji Murono; Hiroshi Nagata; Hiroaki Nozawa; Kazushige Kawai; Keisuke Hata; Toshiaki Tanaka; Takeshi Nishikawa; Yasutaka Shuno; Kazuhito Sasaki; Soichiro Ishihara
Journal:  Int J Colorectal Dis       Date:  2019-02-09       Impact factor: 2.571

3.  Estimation of Solid Tumor Doubling Times from Progression-Free Survival Plots Using a Novel Statistical Approach.

Authors:  Katherine Kay; Keith Dolcy; Robert Bies; Dhaval K Shah
Journal:  AAPS J       Date:  2019-02-08       Impact factor: 4.009

4.  A statistical model for cancer host survival.

Authors:  A Dunne; I A Kinsella
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

Review 5.  Current management of melanoma.

Authors:  H F Seigler; B F Fetter
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

6.  Surgical resection and adjunctive immunotherapy for selected patients with multiple pulmonary metastases.

Authors:  D L Morton; W L Joseph; A S Ketcham; G W Geelhoed; P C Adkins
Journal:  Ann Surg       Date:  1973-09       Impact factor: 12.969

7.  A statistical method for evaluating a tumour treatment.

Authors:  A Kinsella; A Dunne; P G Maddock
Journal:  Ir J Med Sci       Date:  1985-11       Impact factor: 1.568

8.  Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation.

Authors:  I Yokoyama; B Carr; H Saitsu; S Iwatsuki; T E Starzl
Journal:  Cancer       Date:  1991-11-15       Impact factor: 6.860

9.  Choroidal melanoma growth patterns.

Authors:  D H Char; D C Heilbron; R P Juster; R D Stone
Journal:  Br J Ophthalmol       Date:  1983-09       Impact factor: 4.638

Review 10.  Diagnostic techniques: their strengths and weaknesses.

Authors:  J Husband
Journal:  Br J Cancer Suppl       Date:  1980-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.